Vose J - Search Results

1

The stromal cell marker SPARC predicts for survival in patients with diffuse large B-cell lymphoma treated with rituximab.

Meyer PN, Fu K, Greiner T, Smith L, Delabie J, Gascoyne R, Ott G, Rosenwald A, Braziel R, Campo E, Vose J, Lenz G, Staudt L, Chan W, Weisenburger DD. Meyer PN, et al. Among authors: vose j. Am J Clin Pathol. 2011 Jan;135(1):54-61. doi: 10.1309/AJCPJX4BJV9NLQHY. Am J Clin Pathol. 2011. PMID: 21173124

2

Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: clinical course and patient follow-up.

Vose JM, Bierman PJ, Anderson JR, Kessinger A, Pierson J, Nelson J, Frappier B, Schmit-Pokorny K, Weisenburger DD, Armitage JO. Vose JM, et al. Blood. 1992 Oct 15;80(8):2142-8. Blood. 1992. PMID: 1356515 Free article.

3

Bone marrow transplantation for peripheral T-cell lymphoma in children and adolescents.

Gordon BG, Warkentin PI, Weisenburger DD, Vose JM, Sanger WG, Strandjord SE, Anderson JR, Verdirame JD, Bierman PJ, Armitage JO, et al. Gordon BG, et al. Among authors: vose jm. Blood. 1992 Dec 1;80(11):2938-42. Blood. 1992. PMID: 1450419 Free article.

4

Central nervous system involvement in patients with diffuse aggressive non-Hodgkin's lymphoma.

Bashir RM, Bierman PJ, Vose JM, Weisenburger DD, Armitage JO. Bashir RM, et al. Among authors: vose jm. Am J Clin Oncol. 1991 Dec;14(6):478-82. doi: 10.1097/00000421-199112000-00004. Am J Clin Oncol. 1991. PMID: 1720278

5

Histologic grade does not predict prognosis in optimally treated, advanced-stage nodular sclerosing Hodgkin's disease.

Masih AS, Weisenburger DD, Vose JM, Bast MA, Armitage JO. Masih AS, et al. Among authors: vose jm. Cancer. 1992 Jan 1;69(1):228-32. doi: 10.1002/1097-0142(19920101)69:1<228::aid-cncr2820690137>3.0.co;2-9. Cancer. 1992. PMID: 1727667

6

Autologous bone marrow transplantation for patients with relapsed Hodgkin's disease.

Armitage JO, Bierman PJ, Vose JM, Anderson JR, Weisenburger DD, Kessinger A, Reed EC, Vaughan WP, Coccia PF, Purtilo DT. Armitage JO, et al. Among authors: vose jm. Am J Med. 1991 Dec;91(6):605-11. doi: 10.1016/0002-9343(91)90213-h. Am J Med. 1991. PMID: 1750430

7

The therapy of non-Hodgkin's lymphomas. Introduction and overview.

Vose JM, Bierman PJ, Weisenburger DD, Armitage JO. Vose JM, et al. Hematol Oncol Clin North Am. 1991 Oct;5(5):845-52. Hematol Oncol Clin North Am. 1991. PMID: 1938757 Review.

8

Comparison of high-dose therapy and autologous bone marrow transplantation for T-cell and B-cell non-Hodgkin's lymphomas.

Vose JM, Peterson C, Bierman PJ, Weisenburger DD, Linder J, Harrington D, Vaughan WP, Kessinger A, Armitage JO. Vose JM, et al. Blood. 1990 Jul 15;76(2):424-31. Blood. 1990. PMID: 1973361 Free article.

9

Diffuse "histiocytic" lymphoma.

Vose JM, Armitage JO. Vose JM, et al. Semin Oncol. 1991 Feb;18(1):50-60. Semin Oncol. 1991. PMID: 1992524 Review. No abstract available.

10

The present status of therapy for patients with aggressive non-Hodgkin's lymphoma.

Vose JM, Armitage JO. Vose JM, et al. Ann Oncol. 1991 Feb;2 Suppl 2:171-6. doi: 10.1007/978-1-4899-7305-4_27. Ann Oncol. 1991. PMID: 2049315 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

585 results

Search Page

Filters